NALOXONE HCI

HF Acquisition Co. LLC, DBA Health First🇺🇸 United States

FDA Page

Effective Date: Jan 27, 2024
Approval ID: 73c1bad3-6ac3-8682-e053-2a91aa0a176a
Products: 1 registered
Version: 9

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

NALOXONE HCI INJECTION, USP 0.4mg/mL 1mL VIA

Quick Stats

Total Products1

Labelers2

Label Sections18

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.